Ostatní
Návod 
Editas Medicine, Inc.
EDIT
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.2B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
-1485%
ROA
-99%
PE
-1
PS
5
Cena 1R
1-5
⌀ Cena
2.43
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
04-03-2026
Poslední dividenda
Profil
Editas Medicine, Inc., společnost zabývající se editací genomu v klinickém stádiu, se zaměřuje na vývoj transformativních genomických léků pro léčbu řady závažných onemocnění. Vyvíjí proprietární platformu pro editaci genů založenou na technologii CRISPR. Společnost vyvíjí EDIT-101, který je ve fázi 1/2 klinické studie pro Leber Congenital Amaurosis 10, která vede k dědičné dětské slepotě. Vyvíjí také EDIT-102 pro léčbu Usherova syndromu 2A, což je forma retinitis pigmentosa, která zahrnuje také ztrátu sluchu; autosomálně dominantní retinitis pigmentosa, progresivní forma degenerace sítnice; a EDIT-301 pro léčbu srpkovité buňky a transfuzí závislé beta-talasemie. Kromě toho společnost vyvíjí genově upravené léky na buňky Natural Killer pro léčbu solidních nádorových onemocnění; alfa-beta-T buňky pro mnohočetné nádorové onemocnění; a gama delta-T buněčné terapie pro léčbu nádorových onemocnění, stejně jako má první objevný program pro vývoj terapie pro léčbu neurologického onemocnění. Spolupracuje s firmou Juno Therapeutics, Inc. na vývoji umělých T-buněk pro rakovinu, strategické aliance a dohodě o alternativách se společností Allergan Pharmaceuticals International Limited na objevování, vývoji a komercializaci nových léků na úpravu genů pro řadu očních poruch a na výzkumné spolupráci s firmou Asklepios BioPharmaceutical, Inc. na vývoji terapie pro léčbu neurologického onemocnění a na výzkumné spolupráci s firmou AskBio. Společnost byla dříve známá jako Gengine, Inc. a v listopadu 2013 změnila své jméno na Editas Medicine, Inc. Společnost Editas Medicine, Inc. byla založena v roce 2013 a sídlí v Cambridge ve státě Massachusetts.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
246
Založení
2016-02-03
Podobné společnosti
$ 2.37
- $ 0.19
$ 1.19
+ $ 0.01
$ 2.10
- $ 0.12
$ 5.94
+ $ 0.01
$ 1.74
+ $ 0.05
$ 3.29
+ $ 0.02
$ 4.24
+ $ 0.01
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 40.5 | 40.5 | 32.3 | 78.1 | 19.7 | 25.5 | 90.7 | 20.5 | 31.9 | 13.7 | 6.1 | 1.6 | 0.0 | |
| Cost of Revenues | 0.0 | 0.0 | 0.0 | 177.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 40.5 | 40.5 | 32.3 | -99.5 | 19.7 | 25.5 | 90.7 | 20.5 | 31.9 | 13.7 | 6.1 | 1.6 | 0.0 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 24.7 | 7.5 | 3.6 | 4.7 | 30.6 | 0.1 | 0.5 | 1.1 | 60.0 | 5.3 | |
| Cost of Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.6 | 1.4 | 1.4 | 1.5 | 1.5 | |
| Gross Profit | 24.7 | 7.5 | 3.6 | 4.7 | 30.6 | -1.5 | -0.9 | -0.3 | 58.6 | 3.8 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 177.7 | 175.0 | 142.5 | 158.0 | 96.9 | 90.7 | 83.2 | 57.0 | 18.8 | 5.1 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 69.7 | 70.7 | 76.2 | 67.6 | 64.6 | 55.0 | 50.5 | 46.3 | 18.1 | 7.7 | |
| Depreciation & Amortization | 5.3 | 5.3 | 5.8 | 6.1 | 6.3 | 5.1 | 4.0 | -0.1 | 3.3 | 2.7 | 1.2 | 0.5 | 0.2 | |
| Total Operating Expenses | 206.8 | 139.9 | 283.5 | 247.3 | 245.7 | 218.7 | 225.6 | 161.5 | 145.7 | 133.7 | 103.2 | 36.9 | 12.7 | |
| Operating Income | -166.3 | -99.3 | -251.2 | -169.2 | -226.0 | -193.1 | -134.8 | -140.9 | -113.7 | -119.9 | -97.2 | -35.3 | -12.7 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 68.1 | 5.3 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 14.5 | 15.0 | ||
| Depreciation & Amortization | 0.8 | 0.7 | 1.8 | 1.9 | 1.4 | 1.6 | 1.4 | 1.4 | 1.5 | 1.5 | ||
| Total Operating Expenses | 38.8 | 32.1 | 55.1 | 80.8 | 77.2 | 64.1 | 71.0 | 66.7 | 82.5 | 55.5 | ||
| Operating Income | -14.0 | -24.5 | -51.5 | -76.2 | -46.6 | -65.7 | -71.9 | -67.0 | -24.0 | -45.0 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 8.3 | 14.1 | 17.6 | 4.2 | 2.3 | 2.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 0.0 | 6.2 | 0.0 | 0.0 | 4.2 | 0.0 | 0.0 | -7.3 | -3.4 | 1.0 | -0.1 | 0.1 | 0.0 | |
| Other Expense | 6.2 | -60.7 | 14.1 | 16.0 | 5.5 | 0.6 | 18.9 | 7.2 | 0.3 | 0.6 | -0.1 | -37.4 | -0.9 | |
| IBT | -160.1 | -160.1 | -237.1 | -153.2 | -220.4 | -192.5 | -116.0 | -133.7 | -110.0 | -120.3 | -97.2 | -72.9 | -13.7 | |
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | -16.1 | -7.4 | -6.6 | -10.3 | -3.1 | -1.1 | -1.3 | -37.8 | -0.9 | |
| Net Income | -160.1 | -160.1 | -237.1 | -153.2 | -204.4 | -185.1 | -109.4 | -123.5 | -110.0 | -120.3 | -97.2 | -72.9 | -13.7 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | -6.6 | 1.8 | 2.1 | 2.7 | 1.2 | 3.5 | 4.3 | 5.0 | 5.1 | 5.1 | ||
| Interest Expense | -6.6 | 2.4 | 2.0 | 2.2 | 0.0 | 0.0 | 0.0 | 0.0 | 3.5 | 0.0 | ||
| Other Expense | 8.4 | -0.6 | -1.7 | 0.1 | 1.2 | 3.5 | 4.3 | 5.0 | 5.1 | 5.1 | ||
| IBT | -5.6 | -25.1 | -53.2 | -76.1 | -45.4 | -62.1 | -67.6 | -62.0 | -18.9 | -45.0 | ||
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.3 | -1.5 | ||
| Net Income | -5.6 | -25.1 | -53.2 | -76.1 | -45.4 | -62.1 | -67.6 | -62.0 | -18.9 | -45.0 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-2.02 | $-2.98 | $-2.74 | $-1.87 | $-2.47 | $-2.33 | $-2.98 | $-3.02 | $-2.04 | $-0.89 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-2.02 | $-2.98 | $-2.74 | $-1.87 | $-2.47 | $-2.33 | $-2.98 | $-3.02 | $-2.04 | $-0.89 | |
| Shares Outstanding | 88.7 | 88.7 | 82.3 | 76.0 | 68.7 | 67.6 | 58.6 | 50.0 | 47.1 | 40.3 | 32.2 | 35.7 | 15.4 | |
| Diluted Shares Outstanding | 88.7 | 88.7 | 82.3 | 76.0 | 68.7 | 67.6 | 58.6 | 50.0 | 47.1 | 40.3 | 32.2 | 35.7 | 15.4 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.23 | $-0.55 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.23 | $-0.55 | ||
| Shares Outstanding | 88.7 | 90.1 | 84.4 | 83.1 | 82.6 | 82.5 | 82.3 | 81.9 | 81.7 | 81.6 | ||
| Diluted Shares Outstanding | 88.7 | 90.1 | 84.4 | 83.1 | 82.6 | 82.5 | 82.3 | 81.9 | 81.7 | 81.6 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 64.4 | 131.5 | 123.7 | 141.5 | 203.5 | 139.7 | 238.2 | 134.8 | 146.6 | 185.3 | 143.2 | 10.6 | 2.0 | |
| Short Term Investments | 214.7 | 138.4 | 199.5 | 202.8 | 296.3 | 262.4 | 219.0 | 234.2 | 182.5 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 279.1 | 269.9 | 323.1 | 437.4 | 619.9 | 511.8 | 457.1 | 369.0 | 329.1 | 185.3 | 143.2 | 10.6 | 2.0 | |
| Accounts Receivable | 0.2 | 16.3 | 10.2 | 5.1 | 0.3 | 6.0 | 0.4 | 0.0 | 0.7 | 0.1 | 1.0 | 0.0 | 0.0 | |
| Inventory | 0.0 | 0.0 | 0.0 | -93.1 | -120.1 | -109.7 | 0.0 | 2.9 | 1.9 | 1.7 | 0.8 | 0.0 | 0.0 | |
| Other Current Assets | 7.0 | 3.1 | 7.5 | 7.3 | 7.2 | 10.9 | 6.3 | 2.9 | 0.5 | 0.1 | 0.0 | 0.1 | 0.1 | |
| Total Current Assets | 286.4 | 289.3 | 340.8 | 356.8 | 507.3 | 419.1 | 463.8 | 374.8 | 332.2 | 187.2 | 145.0 | 10.7 | 2.1 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 165.6 | 138.5 | 138.7 | 131.5 | 95.8 | 64.4 | 69.2 | 123.7 | 82.5 | 220.8 | |
| Short Term Investments | 0.0 | 40.0 | 82.3 | 138.4 | 169.3 | 214.7 | 226.9 | 199.5 | 267.1 | 211.2 | |
| Total Cash & ST Investments | 165.6 | 178.5 | 221.0 | 269.9 | 265.1 | 279.1 | 296.2 | 323.1 | 446.4 | 480.0 | |
| Accounts Receivable | 8.1 | 0.6 | 0.5 | 16.3 | 0.1 | 0.2 | 0.2 | 10.2 | 2.4 | 2.3 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -9.0 | -48.1 | |
| Other Current Assets | 3.1 | 3.7 | 3.4 | 3.1 | 5.9 | 7.0 | 9.1 | 7.5 | 6.6 | 6.7 | |
| Total Current Assets | 176.9 | 182.8 | 224.8 | 289.3 | 271.1 | 286.4 | 305.6 | 340.8 | 446.4 | 441.0 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 51.1 | 47.1 | 45.7 | 59.2 | 43.3 | 39.1 | 39.6 | 40.2 | 39.4 | 40.4 | 2.1 | 1.1 | 0.1 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 43.1 | 0.0 | 104.0 | 93.1 | 120.1 | 109.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 4.3 | 5.2 | 8.6 | 5.3 | 6.8 | 4.7 | 5.4 | 5.4 | 1.6 | 1.6 | 2.2 | 0.4 | 0.3 | |
| Total Long-Term Assets | 98.4 | 52.3 | 158.3 | 157.6 | 170.2 | 153.5 | 45.0 | 45.6 | 41.1 | 42.0 | 4.4 | 1.5 | 0.4 | |
| Total Assets | 384.8 | 341.6 | 499.2 | 514.3 | 677.5 | 572.6 | 508.9 | 420.4 | 373.3 | 229.2 | 149.4 | 12.2 | 2.5 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 21.9 | 23.6 | 34.6 | 47.1 | 51.1 | 51.1 | 44.7 | 45.7 | 43.5 | 47.7 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 3.9 | 43.1 | 80.6 | 107.9 | 96.8 | 48.1 | |
| Other Long-Term Assets | 3.0 | 4.2 | 4.2 | 5.2 | 1.4 | 4.3 | 9.5 | 4.7 | -82.1 | 5.3 | |
| Total Long-Term Assets | 24.9 | 27.8 | 38.8 | 52.3 | 56.4 | 98.4 | 134.8 | 158.3 | 58.2 | 101.0 | |
| Total Assets | 201.8 | 210.6 | 263.7 | 341.6 | 327.6 | 384.8 | 440.3 | 499.2 | 504.7 | 542.0 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 13.8 | 5.5 | 8.3 | 9.5 | 5.1 | 6.4 | 5.8 | 5.3 | 4.0 | 4.6 | 1.4 | 2.6 | 0.4 | |
| Short-Term Debt | 18.2 | 14.7 | 24.3 | 11.1 | 10.3 | 6.8 | 5.8 | 12.8 | 7.5 | 10.0 | 0.0 | 0.1 | 0.0 | |
| Other Current Liabilities | 27.7 | 45.9 | 22.4 | 31.3 | 20.2 | 24.0 | 24.8 | 2.0 | 11.9 | -7.6 | 5.5 | 1.8 | 1.7 | |
| Current Liabilities | 74.3 | 77.2 | 63.2 | 60.1 | 46.9 | 58.2 | 60.0 | 35.9 | 36.7 | 33.1 | 6.9 | 6.2 | 2.1 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 3.2 | 6.7 | 5.5 | 5.5 | 12.5 | 13.8 | 8.0 | 8.3 | 10.4 | 8.1 | |
| Short-Term Debt | 6.1 | 6.1 | 13.2 | 14.7 | 16.4 | 18.2 | 12.4 | 24.3 | 19.4 | 20.7 | |
| Other Current Liabilities | -1.7 | 48.1 | 47.5 | 45.9 | 28.8 | 27.7 | 31.5 | 22.4 | 20.6 | 17.6 | |
| Current Liabilities | 61.8 | 65.9 | 73.1 | 77.2 | 72.4 | 74.3 | 66.5 | 63.2 | 58.6 | 54.5 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 20.5 | 20.4 | 24.4 | 32.9 | 16.1 | 19.3 | 23.3 | 32.4 | 33.4 | 35.1 | 199.9 | 0.3 | 2.1 | |
| Capital Leases | 20.5 | 35.0 | 36.5 | 43.9 | 26.4 | 26.1 | 29.1 | 32.4 | 33.4 | 35.1 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -23.3 | 0.0 | 0.0 | 0.4 | 0.3 | 0.0 | 0.0 | |
| Total Liabilities | 152.8 | 207.3 | 150.1 | 153.6 | 123.8 | 179.0 | 246.4 | 184.2 | 165.2 | 94.6 | 232.5 | 27.5 | 4.2 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 13.6 | 15.0 | 18.0 | 20.4 | 22.1 | 20.5 | 21.8 | 24.4 | 24.9 | 26.9 | |
| Capital Leases | 19.7 | 21.1 | 31.1 | 35.0 | 38.5 | 20.5 | 34.1 | 24.4 | 34.6 | 37.2 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -60.7 | |
| Total Liabilities | 188.3 | 191.4 | 201.2 | 207.3 | 151.9 | 152.8 | 145.9 | 150.1 | 144.2 | 142.0 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -1,360.9 | -1,468.4 | -1,231.4 | -1,078.1 | -857.7 | -665.2 | -549.2 | -416.3 | -305.9 | -185.5 | -88.3 | -15.4 | -1.8 | |
| Comprehensive Income | -0.4 | 0.3 | 0.2 | -3.6 | -0.5 | 0.0 | 0.1 | 0.0 | -0.1 | -229.2 | 0.0 | 0.0 | 0.0 | |
| Total Common Equity | 232.0 | 134.3 | 349.1 | 360.7 | 553.6 | 393.6 | 262.4 | 236.2 | 208.1 | 134.6 | -83.1 | -15.3 | -1.8 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -1,622.9 | -1,597.8 | -1,544.5 | -1,468.4 | -1,423.0 | -1,360.9 | -1,293.3 | -1,231.4 | -1,212.5 | -1,167.5 | |
| Comprehensive Income | 0.0 | 0.0 | 0.1 | 0.3 | 0.5 | -0.4 | -0.3 | 0.2 | -1.5 | -2.3 | |
| Total Common Equity | 13.5 | 19.2 | 62.4 | 134.3 | 175.6 | 232.0 | 294.4 | 349.1 | 360.5 | 399.9 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 38.7 | 35.0 | 36.5 | 43.9 | 26.4 | 26.1 | 29.1 | 32.4 | 33.4 | 35.1 | 199.9 | 0.4 | 2.1 | |
| Book Value | 232.0 | 134.3 | 349.1 | 360.7 | 553.6 | 393.6 | 262.4 | 236.2 | 208.1 | 134.6 | -83.1 | -15.3 | -1.8 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 13.5 | 19.2 | 62.4 | 134.3 | 175.6 | 232.0 | 294.4 | 349.1 | 360.5 | 399.9 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -193.5 | -160.1 | -237.1 | -153.2 | -220.4 | -192.5 | -116.0 | -133.7 | -110.0 | -120.3 | -97.2 | -72.9 | -13.7 | |
| Depreciation & Amortization | 5.8 | 5.3 | 5.8 | 6.1 | 6.3 | 5.1 | 4.0 | 2.8 | 3.3 | 2.7 | 1.2 | 0.5 | 0.2 | |
| Stock-Based Compensation | 22.7 | 10.0 | 21.4 | 19.8 | 29.3 | 43.4 | 23.2 | 27.2 | 26.6 | 23.4 | 16.9 | 3.5 | 0.1 | |
| Change Working Capital | 7.7 | -31.2 | 3.5 | -1.6 | 8.2 | -21.4 | -102.2 | 65.9 | 26.9 | 70.7 | 18.5 | 63.1 | 4.1 | |
| Change In Accounts Receivable | 2.0 | 1.1 | -6.1 | -5.0 | -4.9 | 5.8 | -5.6 | -0.4 | 0.6 | -0.6 | 0.9 | -1.0 | 0.0 | |
| Change In Accounts Payable | 5.7 | -2.9 | -2.3 | -1.5 | 4.4 | -1.1 | 0.9 | 0.3 | 1.8 | -1.5 | 3.3 | -1.4 | 2.2 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.3 | -5.7 | 10.7 | 1.6 | -8.9 | 13.1 | 4.8 | 0.0 | |
| Other Non-cash Items | 11.8 | 10.8 | -3.9 | -3.2 | -0.7 | 1.7 | 27.6 | -2.9 | 11.2 | 14.2 | 10.6 | 0.3 | 0.7 | |
| Cash from Operations | -164.6 | 0.0 | 0.0 | -132.2 | -177.3 | -163.8 | -179.8 | -40.7 | -45.7 | -9.4 | -49.9 | -5.4 | -8.7 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -5.6 | -25.1 | -53.2 | -76.1 | -45.4 | -62.1 | -67.6 | -62.0 | -18.9 | -45.0 | |
| Depreciation & Amortization | 1.4 | 0.7 | 1.6 | 1.9 | 1.4 | 1.6 | 1.4 | 1.4 | 1.5 | 1.5 | |
| Stock-Based Compensation | 2.1 | 2.2 | 2.7 | 3.0 | 4.0 | 4.8 | 5.0 | 7.6 | 5.3 | 4.7 | |
| Change Working Capital | -33.2 | -11.0 | -4.6 | 17.6 | -12.1 | 4.3 | 6.4 | 4.8 | -8.1 | 4.6 | |
| Change In Accounts Receivable | -7.0 | -7.5 | -0.1 | 15.8 | -16.1 | 0.1 | 0.0 | 9.9 | -7.8 | -0.1 | |
| Change In Accounts Payable | -0.6 | -3.6 | 1.3 | 0.0 | -7.0 | -1.3 | 7.4 | -1.5 | -2.6 | 2.4 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | -1.1 | 2.3 | 3.4 | 5.8 | 1.3 | -1.2 | -2.3 | -1.7 | 16.5 | -3.0 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -22.2 | -35.5 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -6.9 | -0.6 | -8.8 | -4.7 | -4.1 | -8.0 | -7.2 | -6.2 | -4.8 | -2.1 | -3.5 | -1.4 | -1.2 | |
| Acquisitions | 38.4 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -276.6 | 0.0 | -86.2 | -258.5 | -315.2 | -408.9 | -458.4 | -342.2 | -459.4 | -375.3 | 0.0 | 0.2 | 0.0 | |
| Sales of Investment | 290.7 | 139.0 | 257.2 | 259.5 | 433.4 | 362.4 | 325.0 | 360.5 | 411.0 | 193.5 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 14.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | -1.6 | -0.2 | 0.0 | |
| Cash from Investing | 7.2 | 0.0 | 0.0 | -3.7 | 114.1 | -54.5 | -140.5 | 12.3 | -53.1 | -183.8 | -5.1 | -1.4 | -1.2 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.1 | -0.4 | 0.2 | -0.1 | -0.5 | -2.9 | -3.5 | -1.9 | -1.3 | -0.2 | |
| Acquisitions | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -64.1 | 102.6 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -86.2 | -38.8 | -151.6 | |
| Sales of Investment | 0.0 | 40.0 | 42.5 | 56.5 | 31.5 | 86.9 | 55.4 | 83.4 | 102.9 | 49.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 64.1 | -102.6 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 62.8 | -102.8 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.9 | -1.4 | -0.6 | -2.1 | 0.0 | |
| Debt Issued | 1.5 | 35.0 | -1.5 | -7.4 | 17.6 | 0.2 | -2.9 | -3.3 | -0.2 | -0.3 | -164.3 | 201.6 | -1.7 | |
| Issuance of Common Stock | 1.0 | 0.0 | 0.0 | 117.1 | 1.0 | 249.5 | 203.7 | 116.3 | 76.8 | 154.1 | 97.5 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.8 | -143.2 | 0.0 | |
| Other Financing Activities | 1.0 | 0.0 | 0.0 | 0.0 | 0.3 | 32.6 | 20.4 | 15.5 | 11.0 | 1.8 | 1.0 | 284.6 | 18.4 | |
| Cash from Financing | 1.0 | 0.0 | 0.0 | 118.0 | 1.3 | 282.1 | 224.1 | 131.8 | 86.9 | 154.5 | 97.2 | 139.4 | 18.5 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 19.7 | -1.5 | -10.0 | -3.9 | -3.5 | -0.2 | 4.6 | -2.4 | 1.9 | -2.6 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 0.0 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 0.0 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -156.4 | 13.9 | 7.9 | -17.9 | -62.0 | 63.8 | -96.2 | 103.4 | -11.9 | -38.7 | 42.1 | 132.6 | 8.6 | |
| Closing Cash Balance | 64.4 | 149.3 | 135.4 | 127.5 | 145.4 | 207.4 | 143.6 | 239.8 | 136.4 | 148.2 | 185.3 | 143.2 | 10.6 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -19.0 | 25.9 | -0.2 | 7.2 | 35.7 | 31.4 | -4.8 | -54.4 | 41.1 | -138.3 | |
| Closing Cash Balance | 149.3 | 168.3 | 142.4 | 142.6 | 135.4 | 99.7 | 64.4 | 69.2 | 123.7 | 86.4 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -171.5 | -165.8 | -219.1 | -136.9 | -181.5 | -171.8 | -187.0 | -46.8 | -50.5 | -11.5 | -53.4 | -6.8 | -9.9 | |
| Real Free Cash Flow | -194.2 | -175.8 | -240.5 | -156.7 | -210.8 | -215.2 | -210.2 | -74.1 | -77.1 | -34.8 | -70.3 | -10.3 | -9.9 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -36.4 | -31.3 | -50.2 | -47.9 | -51.3 | -55.5 | -60.6 | -51.7 | -23.5 | -35.7 | |
| Real Free Cash Flow | -38.6 | -33.5 | -52.9 | -50.9 | -55.3 | -60.3 | -65.6 | -59.3 | -28.9 | -40.4 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -1.3 | -8.8 | -1.4 |
| P/S | 5.1 | 66.3 | 9.4 |
| P/B | 15.4 | 4.5 | 5.2 |
| P/FCF | -1.2 | -13.4 | -1.5 |
| Market cap | $0.2 | $6.6 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 9.7 % | 10.5 % | 0 % |
| Debt to Income | -12.3 % | -26.7 % | 0 % |
| Debt to Free cash flow | -11.2 % | -448.8 % | 0 % |
| Interest expense percentage | 0 % | 0.6 % | 44.7 % |
| Current ratio | 2.9 | 8.9 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -1189.8 % | -111.9 % | 0 % |
| ROA | -79.3 % | -36.3 % | 0 % |
| CapEx to Revenue | 2 % | 42.1 % | 0 % |
| RaD to Revenue | 0 % | 682.4 % | 0 % |
| ROEM | 164,715.4 | 83901.3 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 100 % | 69.3 % | 68.7 % |
| Operating margin | -428.7 % | -1084.8 % | 35.5 % |
| Net margin | -430.8 % | -1782.5 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | -0.2 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 90.1 mil | 54.7 mil |
| Employee count | 0.2 tis | 0.2 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
